中国经济网北京12月1日讯博菲电气（001255）(001255.SZ)近日披露《关于公司控股股东、实际控制人 的一致行动人减持公司股份的预披露公告》。 根据公告，控股股东、实际控制人的一致行动人海宁云格投资合伙企业(有限合伙)(以下简称"海宁云 格")、海宁聚成投资合伙企业(有限合伙)(以下简称"海宁聚成")计划通过集中竞价交易方式和大宗交易方 式合计减持公司股份数量累计不超过2,550,000股(占公司总股本比例2.9497%)，其中，以集中竞价交易 方式减持的，计划在公告披露之日起15个交易日后的3个月内进行，且3个月内减持股份总数不超过公司 股份总数的1%；以大宗交易方式减持的，计划在公告披露之日起15个交易日后的3个月内进行，且3个 月内减持股份总数不超过公司股份总数的2%。 按上一交易日公司收盘价31.03元计算，海宁云格、海宁聚成拟减持套现合计约79,126,500元。 博菲电气首次公开发行股票募集资金总额为39540.00万元，募集资金净额为33134.83万元。博菲电气于 2022年8月26日披露的招股说明书显示，其拟募集资金33134.83万元，拟分别用于年产35000吨轨道交通 和新能源 ...

Core Points - Changchuan Technology (300604) closed at 77.11 yuan on November 28, 2025, up 1.58% from the previous trading day, with a total market capitalization of 48.919 billion yuan [1] - The company plans to issue shares to specific investors to raise no more than 313.20305 million yuan for semiconductor equipment R&D and to supplement working capital [1] - The number of shares to be issued will not exceed 30% of the total share capital before issuance, amounting to 188,648,115 shares, with no more than 35 investors involved [1] - The fundraising aims to enhance the company's technological capabilities, promote product upgrades, and strengthen capital [1] - The issuance will not result in a change of control of the company and is subject to approval by the Shenzhen Stock Exchange and registration with the CSRC [1]

编辑 ｜ 钉钉 网上、网下投资者放弃认购股数全部由保荐人（主承销商）包销，包销股份的数量为29302股，包销 金额为334.86万元，包销股份数量占扣除最终战略配售部分后本次发行数量的比例约为0.05%，包销 股份数量占本次发行总规模的比例约为0.04%。 11月27日晚间，摩尔线程发布首次公开发行股票并在科创板上市发行结果公告，本次发行的网上、网 下认购缴款工作已于2025年11月26日（T+2日）结束。 公告显示，网上投资者缴款认购的股份数量为1677.07万股，缴款认购的金额为19.17亿元，放弃认购 数量为29302股，放弃认购金额为334.86万元。网下投资者缴款认购的股份数量为3920万股，有效 缴款认购的金额为44.8亿元，放弃认购数量为0股。 ...

摩尔线程发布首次公开发行股票并在科创板上市发行结果公告，本次发行的网上、网下认购缴款工作已于2025年11月26日（T+2日）结束。 网下投资者缴款认购的股份数量为3920万股，有效缴款认购的金额为44.8亿元，放弃认购数量为0股。 网上、网下投资者放弃认购股数全部由保荐人（主承销商）包销，包销股份的数量为29302股，包销金额为334.86万元，包销股份数量占扣除最终战 略配售部分后本次发行数量的比例约为0.05%，包销股份数量占本次发行总规模的比例约为0.04%。 网上投资者缴款认购的股份数量为1677.07万股，缴款认购的金额为19.17亿元， 放弃认购数量为29302股，放弃认购金额为334.86万元。 ...

中国经济网北京11月26日讯 万润新能(688275.SH)今日收报75.10元，跌幅4.28%。该股目前处于破 发状态。 万润新能于2022年9月29日在上交所科创板上市，公开发行2130.3795万股，发行价格299.88元/股， 保荐机构为东海证券股份有限公司，保荐代表人为盛玉照、江成祺。 万润新能首次公开发行股票的发行费用为24,295.94万元，其中，保荐及承销费用21,200.00万元。 万润新能于2023年5月24日披露的2022年年度权益分派实施公告显示，本次利润分配及转增股本以 方案实施前的公司总股本85,215,178股为基数，每股派发现金红利3.52元(含税)，以资本公积金向全体股 东每股转增0.48股，共计派发现金红利299,957,426.56元，转增40,903,285股，本次分配后总股本为 126,118,463股。本次权益分派股权登记日为2023年5月30日，除权除息日为2023年5月31日。 上市首日，万润新能盘中创下最高价259.99元，为该股上市以来最高价。 万润新能首次公开发行股票募集资金总额638,858.20万元，扣除发行费用后，募集资金净额为 614,562.26 ...

凡参与网上发行申购摩尔线程首次公开发行 A 股并在科创板上市股票的投 资者持有的申购配号尾数与上述号码相同的,则为中签号码。中签号码共有 33,600个,每个中签号码只能认购 500 股摩尔线程 A 股股票。 摩尔线程发布首次公开发行股票并在科创板上市网下初步配售结果及网上中签结果公告，本次发行战略配售的缴款及配售工作已结束，本次发行的 参与战略配售的投资者均按承诺参与了本次发行的战略配售。经确认，《发行公告》中披露参与战略配售的投资者参与本次发行的战略配售有效。 本次发行最终战略配售结果如下： 下载财联社APP获取更多资讯 | 序 | 参与战略配售的投资 | 参与战略配售的投资者 | 获配股数 | 获配股数 占本次发 | 获配金额 | 限售期 | | --- | --- | --- | --- | --- | --- | --- | | ਥੋ | 者名称 | 类型 | (股) | 行数量的 | (元) | (月) | | | | | | 比例 | | | | 1 | 中信证券投资有限公 | 参与科创板跟投的保荐 | 1,400,000 | 2.00% | 159,992,000.00 | 24 | | | ...

Core Points - China Uranium Corporation has received approval for its initial public offering (IPO) of 248.1818 million shares of RMB ordinary shares (A-shares) and has been registered by the China Securities Regulatory Commission [1] - The IPO will be conducted through a combination of strategic placement, offline issuance to qualified investors, and online issuance to the public [1] - The lead underwriters for this issuance are CITIC Securities and CITIC JianTou Securities [1] Group 1 - The initial strategic placement amount is 74.4545 million shares, accounting for 30% of the total issuance, with no need for a reallocation to offline issuance [2] - The offline initial issuance quantity is 121.609273 million shares, representing 70% of the total issuance after deducting the final strategic placement [2] - The online initial issuance quantity is 52.118 million shares, accounting for 30% of the total issuance after deducting the final strategic placement [2] Group 2 - Investors must ensure that their subscription funds are fully paid by November 25, 2025, or their allocation will be invalidated [3] - The online issuance shares have no circulation restrictions and can be traded immediately upon listing [4] - For offline investors, 30% of the allocated shares will have a lock-up period of 6 months, while 70% will be tradable immediately [5] Group 3 - The final strategic placement quantity remains at 74.4545 million shares, with a final online issuance quantity of 121.609 million shares after the reallocation [8] - The online subscription received 14,612,532 valid applications, totaling 280,246,870,500 shares, with a total allocation number of 560,493,741 [7] - The lottery for the online issuance will take place on November 24, 2025, with results announced on November 25, 2025 [9]

Summary of Dogwood Therapeutics Special Meeting Company Overview - **Company**: Dogwood Therapeutics (NasdaqCM:DWTX) - **Event**: 2025 Extraordinary General Meeting - **Date**: November 21, 2025 Key Proposals Discussed 1. **Proposal One**: Approval for the issuance of common stock upon conversion of Series A non-voting convertible preferred stock, par value $0.0001 per share [8] 2. **Proposal Two**: Approval for the issuance of common stock upon conversion of Series A1 non-voting preferred stock, par value $0.0001 per share [9] 3. **Proposal Three**: Approval for the issuance of common stock upon conversion of Series A2 non-voting convertible preferred stock, par value $0.0001 per share [9] 4. **Proposal Four**: Approval of the Dogwood Therapeutics Second Amended and Restated 2020 Equity Incentive Plan [9] 5. **Proposal Five**: Approval for the adjournment of the special meeting to a later date if necessary [9] Voting Results - **Proposal One**: Approved under both Delaware law and NASDAQ Listing Rules [13] - **Proposal Two**: Approved under both Delaware law and NASDAQ Listing Rules [13] - **Proposal Three**: Approved under both Delaware law and NASDAQ Listing Rules [14] - **Proposal Four**: Approved [14] - **Proposal Five**: Approved [14] Additional Information - A quorum was established with more than one-third of the outstanding shares present [6] - The final voting results will be filed with the SEC on Form 8K within four business days after the meeting [16] - The meeting concluded with a focus on improving care for patients suffering from pain and neuropathy [16]

摩尔线程发行价定为114.28元/股，将发行7000万股，网上网下打新日期为11月24日，股票代码 为"688795"。 根据11月20日晚间的公告，此次发行询价共收到286家网下投资者管理的7787个配售对象的初步询价报 价信息，报价区间为88.79～159.57元/股。最终确定发行价格为114.28元/股。 按发行价格114.28元/股和新股发行数量计算，若此次发行成功，预计摩尔线程募集资金总额79.996亿 元，扣除发行费用（不含增值税）约4.24亿元后，预计募集资金净额约为75.76亿元。 其中，南京神傲管理咨询合伙企业（有限合伙）是创始人持股平台，持有摩尔线程5818.6082万股，持 股市值达到66.495亿元；杭州华傲管理咨询合伙企业（有限合伙）为员工持股平台，持有2692.7569万 股，持股市值达到30.77亿元。 实控人张建中直接持有4424.2122万股（发行前持股比例为11.0598%），持股市值约50.56亿元，加上还 间接持股，合计控制摩尔线程36.36%的股份。 除了实控人和合伙人、核心员工身价大涨外，持有摩尔线程股份的上市公司及其他股东的持股市值也大 增。 根据公开消息，和而泰 ...

Core Points - Moore Threads announced its initial public offering (IPO) and listing on the Sci-Tech Innovation Board, with a total of 70 million shares to be issued [1] - The offering price is set at 114.28 yuan per share, aiming to raise a total of 8 billion yuan, with a net amount expected to be 7.576 billion yuan after deducting issuance costs [1] Company Information - Full company name: Moore Threads Intelligent Technology (Beijing) Co., Ltd [2] - Stock code for offline subscription: 688795; online subscription code: 787795 [2] - The total number of shares after the issuance will be approximately 47,002.82 million shares, with the new issuance accounting for 14.89% of the total [2] Issuance Details - The pricing method is based on preliminary inquiries for offline subscriptions, with no further inquiries conducted [2] - The expected total fundraising amount is approximately 799.96 million yuan [3] - Important dates include the offline and online subscription date on November 24, 2025, and the payment deadline on November 26, 2025 [3]